The global halal pharmaceuticals market size is expected to reach USD 205.30 billion by 2034, according to a new study by Polaris Market Research. The report “Halal Pharmaceuticals Market Size, Share, Trends, Industry Analysis Report: By Drug, Dosage Form (Injectables, Tablets & Capsules, Orals, Topicals, and Others), Therapeutic Area, Certification Type, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Halal pharmaceuticals are medications that comply with Islamic law and do not contain any haram (prohibited) components. While there are some similarities between conventional pharmaceutical production and the halal certification process, key differences exist. Halal pharmaceutical ingredients are derived from plants, minerals, water, and animals slaughtered in accordance with Islamic law. Marine creatures are considered halal, and synthetic materials are permitted as long as they are free from impurities (najis) and safe for human consumption.
Government policies, such as taxes, subsidies, and restrictions, significantly influence market growth. In many Muslim-majority countries, regulations mandating halal certifications for pharmaceuticals help drive market demand for compliant products. In addition, subsidies for halal pharmaceutical research and production encourage innovation and investment. Regulatory frameworks promoting halal standards further create a favorable environment for the halal pharmaceuticals market expansion.
The growing demand for organic and environmentally friendly products is one of the major market trends anticipated to drive market development in the coming years. The improving economic climate in Islamic nations is projected to provide several halal pharmaceuticals market opportunities during the forecast period.
Key Highlights of Halal Pharmaceuticals Market
Based on drugs, the prescription drugs segment accounted for the largest market share in 2024, driven by the growing prevalence of chronic illnesses and the rising need for drugs with halal certification.
Based on dosage form, the tablets & capsules segment led the market with a 50% revenue share in 2024. This is primarily attributed to the convenience, patient compliance, and accessibility of tablet and capsule administration among patients.
North America accounted for a significant portion of the global halal medicines market in 2024 due to the region's growing Muslim population and rising consumer awareness of ingredients and sourcing.
The Asia Pacific halal pharmaceuticals market is projected to witness the fastest growth during the forecast period, driven by the significant Muslim population in the region.
Rosemont Pharmaceuticals, EMBIL Pharmaceutical Co., Noor Vitamins, Bosch Pharmaceuticals, Chemical Company of Malaysia Berhad, Pharmaniaga Bhd, Nutramedica Incorporated, and Simpor Pharma Sdn Bhd are a few of the key players in the market.
Polaris Market Research has segmented the global halal pharmaceuticals market report on the basis of drug, dosage form, therapeutic area, certification type, end users, and region:
Halal Pharmaceuticals Market Segmentation
By Drug Outlook (Revenue – USD Billion, 2020–2034)
Over-The-Counter (OTC) drugs
Cosmetics
Prescription Drugs
Nutraceuticals
Medical Devices
By Dosage Form Outlook (Revenue – USD Billion, 2020–2034)
Injectables
Tablets & Capsules
Orals
Topicals
Others
By Therapeutic Area Outlook (Revenue – USD Billion, 2020–2034)
Diabetes
Cardiovascular Diseases
Gastrointestinal Disorders
Anti-Infectives
Respiratory Diseases
Neurological Disorders
Oncology
Others
By Certification Type Outlook (Revenue – USD Billion, 2020–2034)
Halal International Standard
Gulf Standard
Malaysia Standard
Others
By End Users Outlook (Revenue – USD Billion, 2020–2034)
Pharmacies
Hospitals & Clinics
Online Pharmacies
Retailers
Others
By Regional Outlook (Revenue – USD Billion, 2020–2034)
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest of Europe
- China
- Japan
- India
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Saudi Arabia
- UAE
- Israel
- South Africa
- Rest of the Middle East & Africa
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Global Halal Pharmaceuticals Market Insights
- 4.1. Halal Pharmaceuticals Market – Application Snapshot
- 4.2. Halal Pharmaceuticals Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Growing Demand for Halal-Certified Goods
- 4.2.1.2. Increasing Awareness Among Muslim Population
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Regulatory Challenges
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry Among Existing Firms (High)
- 4.4. PESTEL Analysis
- 4.5. Halal Pharmaceuticals Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
- 5. Global Halal Pharmaceuticals Market, by Drug
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 5.3. Over-The-Counter (OTC) Drugs
- 5.3.1. Global Halal Pharmaceuticals Market, by Over-The-Counter (OTC) Drugs, by Region, 2020–2034 (USD Billion)
- 5.4. Cosmetics
- 5.4.1. Global Halal Pharmaceuticals Market, by Cosmetics, by Region, 2020–2034 (USD Billion)
- 5.5. Prescription Drugs
- 5.5.1. Global Halal Pharmaceuticals Market, by Prescription Drugs, by Region, 2020–2034 (USD Billion)
- 5.6. Nutraceuticals
- 5.6.1. Global Halal Pharmaceuticals Market, by Nutraceuticals, by Region, 2020–2034 (USD Billion)
- 5.7. Medical Devices
- 5.7.1. Global Halal Pharmaceuticals Market, by Medical Devices, by Region, 2020–2034 (USD Billion)
- 6. Global Halal Pharmaceuticals Market, by Dosage Form
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 6.3. Injectables
- 6.3.1. Global Halal Pharmaceuticals Market, by Injectables, by Region, 2020–2034 (USD Billion)
- 6.4. Tablets & Capsules
- 6.4.1. Global Halal Pharmaceuticals Market, by Tablets & Capsules, by Region, 2020–2034 (USD Billion)
- 6.5. Orals
- 6.5.1. Global Halal Pharmaceuticals Market, by Orals, by Region, 2020–2034 (USD Billion)
- 6.6. Topicals
- 6.6.1. Global Halal Pharmaceuticals Market, by Topicals, by Region, 2020–2034 (USD Billion)
- 6.7. Others
- 6.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020–2034 (USD Billion)
- 7. Global Halal Pharmaceuticals Market, by Therapeutic Area
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 7.3. Diabetes
- 7.3.1. Global Halal Pharmaceuticals Market, by Diabetes, by Region, 2020–2034 (USD Billion)
- 7.4. Cardiovascular Diseases
- 7.4.1. Global Halal Pharmaceuticals Market, by Cardiovascular Diseases, by Region, 2020–2034 (USD Billion)
- 7.5. Gastrointestinal Diseases
- 7.5.1. Global Halal Pharmaceuticals Market, by Gastrointestinal Diseases, by Region, 2020–2034 (USD Billion)
- 7.6. Anti-infectives
- 7.6.1. Global Halal Pharmaceuticals Market, by Anti-infectives, by Region, 2020–2034 (USD Billion)
- 7.7. Respiratory Diseases
- 7.7.1. Global Halal Pharmaceuticals Market, by Respiratory Diseases, by Region, 2020–2034 (USD Billion)
- 7.8. Neurological Diseases
- 7.8.1. Global Halal Pharmaceuticals Market, by Neurological Diseases, by Region, 2020–2034 (USD Billion)
- 7.9. Oncology
- 7.9.1. Global Halal Pharmaceuticals Market, by Oncology, by Region, 2020–2034 (USD Billion)
- 7.10. Others
- 7.10.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020–2034 (USD Billion)
- 8. Global Halal Pharmaceuticals Market, by Certification Type
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 8.3. Halal International Standard
- 8.3.1. Global Halal Pharmaceuticals Market, by Halal International Standard, by Region, 2020–2034 (USD Billion)
- 8.4. Gulf Standard
- 8.4.1. Global Halal Pharmaceuticals Market, by Gulf Standard, by Region, 2020–2034 (USD Billion)
- 8.5. Malaysia Standard
- 8.5.1. Global Halal Pharmaceuticals Market, by Malaysia Standard, by Region, 2020–2034 (USD Billion)
- 8.6. Others
- 8.6.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020–2034 (USD Billion)
- 9. Global Halal Pharmaceuticals Market, by End Users
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Global Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 9.3. Pharmacies
- 9.3.1. Global Halal Pharmaceuticals Market, by Pharmacies, by Region, 2020–2034 (USD Billion)
- 9.4. Hospitals & Clinics
- 9.4.1. Global Halal Pharmaceuticals Market, by Hospitals & Clinics, by Region, 2020–2034 (USD Billion)
- 9.5. Online Pharmacies
- 9.5.1. Global Halal Pharmaceuticals Market, by Online Pharmacies, by Region, 2020–2034 (USD Billion)
- 9.6. Retailers
- 9.6.1. Global Halal Pharmaceuticals Market, by Retailers, by Region, 2020–2034 (USD Billion)
- 9.7. Others
- 9.7.1. Global Halal Pharmaceuticals Market, by Others, by Region, 2020–2034 (USD Billion)
- 10. Global Halal Pharmaceuticals Market, by Geography
- 10.1. Key Findings
- 10.2. Introduction
- 10.2.1. Halal Pharmaceuticals Market Assessment, by Geography, 2020–2034 (USD Billion)
- 10.3. Halal Pharmaceuticals Market – North America
- 10.3.1. North America: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.3.2. North America: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.3.3. North America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.3.4. North America: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.3.5. North America: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.3.6. Halal Pharmaceuticals Market – US
- 10.3.6.1. US: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.3.6.2. US: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.3.6.3. US: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.3.6.4. US: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.3.6.5. US: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.3.7. Halal Pharmaceuticals Market – Canada
- 10.3.7.1. Canada: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.3.7.2. Canada: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.3.7.3. Canada: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.3.7.4. Canada: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.3.7.5. Canada: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4. Halal Pharmaceuticals Market – Europe
- 10.4.1. Europe: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.2. Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.3. Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.4. Europe: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.5. Europe: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.6. Halal Pharmaceuticals Market – UK
- 10.4.6.1. UK: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.6.2. UK: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.6.3. UK: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.6.4. UK: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.6.5. UK: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.7. Halal Pharmaceuticals Market – France
- 10.4.7.1. France: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.7.2. France: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.7.3. France: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.7.4. France: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.7.5. France: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.8. Halal Pharmaceuticals Market – Germany
- 10.4.8.1. Germany: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.8.2. Germany: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.8.3. Germany: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.8.4. Germany: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.8.5. Germany: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.9. Halal Pharmaceuticals Market – Italy
- 10.4.9.1. Italy: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.9.2. Italy: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.9.3. Italy: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.9.4. Italy: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.9.5. Italy: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.10. Halal Pharmaceuticals Market – Spain
- 10.4.10.1. Spain: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.10.2. Spain: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.10.3. Spain: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.10.4. Spain: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.10.5. Spain: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.11. Halal Pharmaceuticals Market – Netherlands
- 10.4.11.1. Netherlands: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.11.2. Netherlands: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.11.3. Netherlands: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.11.4. Netherlands: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.11.5. Netherlands: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.12. Halal Pharmaceuticals Market – Russia
- 10.4.12.1. Russia: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.12.2. Russia: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.12.3. Russia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.12.4. Russia: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.12.5. Russia: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.4.13. Halal Pharmaceuticals Market – Rest of Europe
- 10.4.13.1. Rest of Europe: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.4.13.2. Rest of Europe: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.4.13.3. Rest of Europe: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.4.13.4. Rest of Europe: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.4.13.5. Rest of Europe: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5. Halal Pharmaceuticals Market – Asia Pacific
- 10.5.1. Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.2. Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.3. Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.4. Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.5. Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.6. Halal Pharmaceuticals Market – China
- 10.5.6.1. China: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.6.2. China: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.6.3. China: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.6.4. China: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.6.5. China: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.7. Halal Pharmaceuticals Market – India
- 10.5.7.1. India: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.7.2. India: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.7.3. India: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.7.4. India: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.7.5. India: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.8. Halal Pharmaceuticals Market – Malaysia
- 10.5.8.1. Malaysia: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.8.2. Malaysia: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.8.3. Malaysia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.8.4. Malaysia: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.8.5. Malaysia: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.9. Halal Pharmaceuticals Market – Japan
- 10.5.9.1. Japan: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.9.2. Japan: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.9.3. Japan: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.9.4. Japan: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.9.5. Japan: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.10. Halal Pharmaceuticals Market – Indonesia
- 10.5.10.1. Indonesia: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.10.2. Indonesia: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.10.3. Indonesia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.10.4. Indonesia: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.10.5. Indonesia: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.11. Halal Pharmaceuticals Market – South Korea
- 10.5.11.1. South Korea: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.11.2. South Korea: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.11.3. South Korea: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.11.4. South Korea: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.11.5. South Korea: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.12. Halal Pharmaceuticals Market – Australia
- 10.5.12.1. Australia: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.12.2. Australia: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.12.3. Australia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.12.4. Australia: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.12.5. Australia: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.5.13. Halal Pharmaceuticals Market – Rest of Asia Pacific
- 10.5.13.1. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.5.13.2. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.5.13.3. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.5.13.4. Rest of Asia Pacific: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.5.13.5. Rest of Asia Pacific: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6. Halal Pharmaceuticals Market – Middle East & Africa
- 10.6.1. Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.2. Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.3. Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.4. Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.5. Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6.6. Halal Pharmaceuticals Market – Saudi Arabia
- 10.6.6.1. Saudi Arabia: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.6.2. Saudi Arabia: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.6.3. Saudi Arabia: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.6.4. Saudi Arabia: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.6.5. Saudi Arabia: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6.7. Halal Pharmaceuticals Market – UAE
- 10.6.7.1. UAE: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.7.2. UAE: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.7.3. UAE: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.7.4. UAE: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.7.5. UAE: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6.8. Halal Pharmaceuticals Market – Israel
- 10.6.8.1. Israel: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.8.2. Israel: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.8.3. Israel: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.8.4. Israel: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.8.5. Israel: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6.9. Halal Pharmaceuticals Market – South Africa
- 10.6.9.1. South Africa: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.9.2. South Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.9.3. South Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.9.4. South Africa: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.9.5. South Africa: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.6.10. Halal Pharmaceuticals Market – Rest of Middle East & Africa
- 10.6.10.1. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.6.10.2. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.6.10.3. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.6.10.4. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.6.10.5. Rest of Middle East & Africa: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.7. Halal Pharmaceuticals Market – Latin America
- 10.7.1. Latin America: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.7.2. Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.7.3. Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.7.4. Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.7.5. Latin America: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.7.6. Halal Pharmaceuticals Market – Mexico
- 10.7.6.1. Mexico: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.7.6.2. Mexico: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.7.6.3. Mexico: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.7.6.4. Mexico: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.7.6.5. Mexico: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.7.7. Halal Pharmaceuticals Market – Brazil
- 10.7.7.1. Brazil: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.7.7.2. Brazil: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.7.7.3. Brazil: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.7.7.4. Brazil: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.7.7.5. Brazil: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.7.8. Halal Pharmaceuticals Market – Argentina
- 10.7.8.1. Argentina: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.7.8.2. Argentina: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.7.8.3. Argentina: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.7.8.4. Argentina: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.7.8.5. Argentina: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 10.7.9. Halal Pharmaceuticals Market – Rest of Latin America
- 10.7.9.1. Rest of Latin America: Halal Pharmaceuticals Market, by Drug, 2020–2034 (USD Billion)
- 10.7.9.2. Rest of Latin America: Halal Pharmaceuticals Market, by Dosage Form, 2020–2034 (USD Billion)
- 10.7.9.3. Rest of Latin America: Halal Pharmaceuticals Market, by Therapeutic Area, 2020–2034 (USD Billion)
- 10.7.9.4. Rest of Latin America: Halal Pharmaceuticals Market, by Certification Type, 2020–2034 (USD Billion)
- 10.7.9.5. Rest of Latin America: Halal Pharmaceuticals Market, by End Users, 2020–2034 (USD Billion)
- 11. Competitive Landscape
- 11.1. Expansion and Acquisition Analysis
- 11.1.1. Expansion
- 11.1.2. Acquisitions
- 11.2. Partnerships/Collaborations/Agreements/Exhibitions
- 12. Company Profiles
- 12.1. Alkem Laboratories Limited
- 12.1.1. Company Overview
- 12.1.2. Financial Performance
- 12.1.3. Product Benchmarking
- 12.1.4. Recent Development
- 12.2. Amgen Inc.
- 12.2.1. Company Overview
- 12.2.2. Financial Performance
- 12.2.3. Product Benchmarking
- 12.2.4. Recent Development
- 12.3. Bosch Pharmaceuticals
- 12.3.1. Company Overview
- 12.3.2. Financial Performance
- 12.3.3. Product Benchmarking
- 12.3.4. Recent Development
- 12.4. Chemical Company of Malaysia Berhad
- 12.4.1. Company Overview
- 12.4.2. Financial Performance
- 12.4.3. Product Benchmarking
- 12.4.4. Recent Development
- 12.5. EMBIL Pharmaceutical Co.
- 12.5.1. Company Overview
- 12.5.2. Financial Performance
- 12.5.3. Product Benchmarking
- 12.5.4. Recent Development
- 12.6. Noor Vitamins
- 12.6.1. Company Overview
- 12.6.2. Financial Performance
- 12.6.3. Product Benchmarking
- 12.6.4. Recent Development
- 12.7. Nutramedica Incorporated
- 12.7.1. Company Overview
- 12.7.2. Financial Performance
- 12.7.3. Product Benchmarking
- 12.7.4. Recent Development
- 12.8. Pharmaniaga Bhd
- 12.8.1. Company Overview
- 12.8.2. Financial Performance
- 12.8.3. Product Benchmarking
- 12.8.4. Recent Development
- 12.9. Rosemont Pharmaceuticals
- 12.9.1. Company Overview
- 12.9.2. Financial Performance
- 12.9.3. Product Benchmarking
- 12.9.4. Recent Development
- 12.10. Simpor Pharma Sdn Bhd
- 12.10.1. Company Overview
- 12.10.2. Financial Performance
- 12.10.3. Product Benchmarking
- 12.10.4. Recent Development
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook